Health
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use Brain Image Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use. Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) -- Research assa
About this update from Siemens Healthineers Ag
[{"type":"image","alt":"Siemens Healthineers","displaySize":"","headline":null,"caption":"Siemens Healthineers","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":70,"url":"https://media.zenfs.com/en/globenewswire.com/ba3dcbab3870ebba2566c111d4510fc0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tYU2sZ8ANiK3JHePv8fE9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/ba3dcbab3870ebba2566c111d4510fc0","width":300,"height":70}},"lazy":false},{"type":"text","content":"Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use","length":155,"tagName":"p"},{"type":"text","content":"Brain Image","length":11,"tagName":"p"},{"type":"image","alt":"Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use.","displaySize":"","headline":null,"caption":"Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use.","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":3840,"height":2160,"url":"https://media.zenfs.com/en/globenewswire.com/086297bbb88afe50192ee7f35178a41a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/VHPWeDNMaVnDYAbYulp6lg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/086297bbb88afe50192ee7f35178a41a","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/sm8KwBvGH4mMsMpkuFUB0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/086297bbb88afe50192ee7f35178a41a","width":1200,"height":675}}},{"type":"text","content":"Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) --","length":60,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Research assays help generate evidence about whether biomarkers can advance disease management","length":94,"tagName":"p"}]},{"val":[{"type":"text","conte...